Furthermore, there has been a nearly 1,500% increase in calls to poison control centers related to accidental overdosing on injected weight-loss drugs, underscoring the urgency of these safety concerns
CMAJ: Canadian Medical Association Journal, 155(5), 519
Food and Drug Administration Wegovy (semaglutide) prescribing information Official dosing, administration, and safety labeling Medication Manufacturer Instructions Novo Nordisk Wegovy Injection Instructions Official injection technique and pen usage Eli Lilly and Company Mounjaro (tirzepatide) Instructions for Use Proper administration and dosing schedule Evidence-Based Research New England Journal of Medicine Once-Weekly Semaglutide in Adults with Overweight or Obesity Landmark clinical trial demonstrating weight loss outcomes National Institutes of Health GLP-1 receptor agonists for obesity treatment Mechanism and long-term effectiveness
LIXI is administered subcutaneously, quickly absorbed into the blood, without biotransformation in the liver, and is degraded by proteolytic enzyme and then eliminated by the kidney (63, 64)